Publications by Dr Mark Hudson - ePrints

Browsing publications by Dr Mark Hudson.

Newcastle Authors	Title	Year
Dr Mark Hudson	Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: A retrospective observational extension study with long-term follow-up (IMPRESS II)	2023
Dr Jess Dyson Dr Alasdair Blain Dr Mark Hudson Professor Stephen Rushton Professor David Jones et al.	Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis	2021
Dr Sam Tingle Dr Emily Thompson Rodrigo Figueiredo Dr Mark Hudson Gourab Sen et al.	Risk factors and impact of early anastomotic biliary complications after liver transplantation: UK registry analysis	2021
Dr Mark Hudson	Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System	2019
Dr Mark Hudson	Hepatocellular Carcinoma as a Complication of Vascular Disease of the Liver After Fontan Procedure	2019
Dr Abdullah Malik Dr Steven Masson Dr Mark Hudson Professor Derek Manas	Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival	2019
Dr Mark Hudson	Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence	2019
Dr Jess Dyson Dr Mark Hudson	Paediatric to adult liver transition services: the state of play in the UK	2019
Dr Mark Hudson Dr James Orr	The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)	2019
Dr Jess Dyson Dr Mark Hudson	Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: Fourth report of the Lancet Standing Commission on Liver Disease in the UK	2018
Dr Mark Hudson Helen Jarvis	Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK	2018
Dr Mark Hudson Helen Jarvis	Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK	2018
Dr Holly Standing Helen Jarvis Dr James Orr Professor Catherine Exley Dr Mark Hudson et al.	General practitioners' experiences and perceptions of early detection of liver disease: a qualitative study in primary care	2018
Dr Mark Hudson	Guidelines on the management of abnormal liver blood tests	2018
Dr Sushma Saksena Dr Mark Hudson	NCEPOD and alcohol-related liver disease, what are the views of those who deliver the service? A survey of consultants and trainees in North Eastern England	2018
Dr Jess Dyson Professor David Jones Dr Mark Hudson	Primary sclerosing cholangitis	2018
Dr Louise Coats Dr John O'Sullivan Dr David Crossland Dr Beate Haugk Dr Mark Hudson et al.	Combined heart-liver transplantation for failing Fontan circulation in a late survivor with single-ventricle physiology.	2017
Dr Beate Haugk Dr Yvonne Bury Dr Louise Coats Dr John O'Sullivan Dr Mark Hudson et al.	Defining the role of liver biopsy in the assessment of liver fibrosis in patients with Fontan circulation	2017
Professor Stuart McPherson Dr Jess Dyson Dr Mark Hudson	Editorial: improving in-hospital management of decompensated cirrhosis by a ‘care bundle’ – hope, frustration and lessons to learn. Authors’ reply	2017
Dr Holly Standing Helen Jarvis Dr James Orr Professor Catherine Exley Dr Mark Hudson et al.	How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences	2017
Dr Jess Dyson Dr Mark Hudson	New metrics for the Lancet Standing Commission on Liver Disease in the UK	2017
Dr Mark Hudson	Should we screen for cirrhosis?	2017
Dr Mark Hudson	The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: A retrospective observational study (IMPRESS)	2017
Dr James Orr Dr Daniel Stow Professor Fiona Matthews Professor Barbara Hanratty Professor David Jones et al.	Eleven-year mortality and referral practices associated with abnormal alanine aminotransferase (ALT) results	2016
Dr Louise Coats Dr David Crossland Dr Mark Hudson Dr John O'Sullivan	Fontan conversion is a dated approach to the failing Fontan	2016
Dr David Crossland Dr Mark Hudson	Fontan-associated liver disease: Implications for heart transplantation	2016
Dr Jess Dyson Professor Chris Lamb Dr Steven Masson Dr Mark Hudson Dr Christian Dipper et al.	Implementation of a “care bundle” improves the management of patients admitted to hospital with decompensated cirrhosis	2016
Dr James Orr Dr Mark Hudson	Natural History of Patients Taking Rifaximin-α for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data	2016
Professor Stuart McPherson Dr Jess Dyson Dr Mark Hudson	Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h	2016
Dr Mark Hudson	The Impact of Rifaximin-Alpha on NHS Hospital Resource Use in UK Patients with Hepatic Encephalopathy: A Retrospective Observational Study (Impress)	2016
Dr James Orr Dr Mark Hudson	The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-alpha	2016
Gourab Sen Dr Mark Hudson Professor Derek Manas	Umbilical Hernia Repair in Cirrhosis: Outcomes and Prognostic Factors in a Liver Transplant Unit	2016
Dr James Orr Dr Mark Hudson	Editorial: prolonged remission from hepatic encephalopathy with rifaximin	2015
Dr Jess Dyson Dr Steven Masson Professor Stuart McPherson Professor Derek Manas Dr Mark Hudson et al.	Experience of Using Advagraf in a Single Liver Transplant Centre in the United Kingdom	2015
Dr Jess Dyson Dr Ahmed Elsharkawy Professor Chris Lamb Dr Ahmad Al-Rifai Emerita Professor Julia Newton et al.	Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output	2015
Dr Jess Dyson Dr Steven Masson Professor Stuart McPherson Dr Mark Hudson	Impact of a Nurse-Led Annual Review Clinic for Liver Transplant Recipients	2015
Dr Jess Dyson Professor Chris Lamb Dr Mark Hudson Professor Stuart McPherson	Implementation and impact of a care bundle for the management of patients with decompensated liver disease	2015
Dr Jess Dyson Dr Mark Hudson	Implementation of the Lancet Standing Commission on Liver Disease in the UK	2015
Dr Jess Dyson Professor Stuart McPherson Dr Steven Masson Dr Mark Hudson	Importance of Health Education in an Annual Review Liver Transplant Clinic in the United Kingdom	2015
Dr James Orr Professor David Jones Dr Mark Hudson	Minimally deranged serum alanine transferase identified in the community: referral practices, prevalence of liver pathology and long term mortality	2015
Dr James Orr Dr Mark Hudson Emeritus Professor Calum McNeil Professor David Jones	The home study (home monitoring in encephalopathy): Rationale and study design	2015
Dr James Orr Dr Mark Hudson	The impact on hospital resource utilisation of Rifaximin-alpha for hepatic encephalopathy in routine clinical practice: Real world data from seven UK liver centres	2015
Dr Mark Hudson	UK guidelines on the management of variceal haemorrhage in cirrhotic patients	2015
Stuart Robinson Dr Steven Masson Dr Mark Hudson Professor Derek Manas	Umbilical hernia repair in cirrhosis: outcomes and prognostic factors in a liver transplant unit	2015
Dr Jess Dyson Dr Mark Hudson Professor Derek Manas Dr Steven Masson	A Positive Complement Dependent Cytotoxic (CDC) Crossmatch Does Not Impact on Patient Survival or Increase the Risk of Acute Cellular Rejection, or Biliary Strictures after Liver Transplantation	2014
Dr Mark Hudson	Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis	2014
Dr Steven Masson Dr Stuart Kendrick Dr Ahmed Elsharkawy Dr Mark Hudson	An 'alcohol contract' has no significant effect on return to drinking after liver transplantation for alcoholic liver disease	2014
Dr James Orr Dr Mark Hudson Professor David Jones	Development and validation of The Newcastle Patient Reported Ascites Measure	2014
Dr James Orr Tara Homer Professor Laura Ternent Emerita Professor Julia Newton Emeritus Professor Calum McNeil et al.	Health related quality of life in people with advanced chronic liver disease	2014
Dr James Orr Tara Homer Professor Laura Ternent Emerita Professor Julia Newton Emeritus Professor Calum McNeil et al.	'Health Related Quality of Life in People with Advanced Chronic Liver Disease'	2014
Dr Jess Dyson Dr Mark Hudson Professor Stuart McPherson	Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapy	2014
Dr James Orr Tara Homer Professor Laura Ternent Professor Luke Vale Dr Mark Hudson et al.	PTU-112 Associations Between Healthcare Resource Utilisation And Health-related Quality Of Life In Cirrhosis	2014
Professor Quentin Anstee Dr Mark Hudson Professor Helen Reeves	Reply to "Hepatocellular carcinoma and the Newcastle-upon-Tyne area"	2014
Dr James Orr Dr Mark Hudson	Resource use associated with hepatic encephalopathy in patients with liver disease	2014
Dr James Orr Dr Mark Hudson	Resource Use Associated with Hepatic Encephalopathy in Patients with Severe Liver Disease	2014
Dr James Orr Dr Mark Hudson	Rifaximin is Efficacious in the Treatment of Chronic Overt Hepatic Encephalopathy: A UK Liver Multi-Centre Experience	2014
Dr James Orr Dr Yvonne Bury Dr Mark Hudson Dr Steven Masson	Liver transplantation for acute liver failure caused by macrophage activation syndrome	2013
Professor Stuart McPherson Dr Samuel Moses Dr Shafiq Rehman Claire Miller Dr Mark Hudson et al.	A pilot of targeted case finding for hepatitis B virus (HBV) and hepatitis C (HCV) in the British South Asian community	2012
Dr Stuart Kendrick Dr Ahmed Elsharkawy Dr Mark Hudson Dr Steven Masson	An “alcohol contract” has not reduced rates of post-transplant drinking following transplantation for alcoholic liver disease	2012
Dr Ahmed Elsharkawy Professor Stuart McPherson Dr Steven Masson Professor Alastair Burt Dr Mark Hudson et al.	Lesson of the Week: Cholestasis secondary to anabolic steroid use in young men	2012
Dr Enid Michael Dr Andrew Turley Dr Samuel Moses Dr Mark Hudson Professor Margaret Bassendine et al.	Pregnant mothers with chronic hepatitis B (HBV): how often is treatment needed?	2012
Dr James Prentis Professor Derek Manas Professor Mike Trenell Dr Mark Hudson Dr Christopher Snowden et al.	Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation	2012
Dr Imran Patanwala Emerita Professor Julia Newton Dr Mark Hudson Professor David Jones	The clinical impact of varices and a new externally validated non-invasive inexpensive tool to predict their presence in patients with PBC	2012
Dr Imran Patanwala Dr Simon Kometa Emerita Professor Julia Newton Dr Mark Hudson Professor David Jones et al.	An externally-validated clinical tool for the prediction of gastro-oesophageal varices in patients with PBC - the Newcastle varices in PBC (NVP) score	2011
Dr Imran Patanwala Dr Mark Hudson	Are UK gastroenterology trainees confident in managing hepatology?	2011
Emerita Professor Julia Newton Dr Mark Hudson Professor David Jones	Morbidity and mortality associated with varices in patients with primary biliary cirrhosis	2011
Dr Imran Patanwala Professor Derek Manas Dr Mark Hudson Professor Helen Reeves	NAFLD and the changing face of hepatocellular cancerER (HCC)	2011
Dr Imran Patanwala Dr John Rose Bryon Jaques Professor Derek Manas Dr Mark Hudson et al.	NAFLD related HCC is rising dramatically in the North of England	2011
Professor Stuart McPherson Professor Derek Manas Dr Mark Hudson Dr Stephen Stewart	Outcomes of liver transplantation for alcoholic liver disease are good, but cancer is a frequent cause of death	2011
Dr Imran Patanwala Dr Mark Hudson	The current state of hepatology training in UK: Results form a national trainee survey	2011
Professor Stuart McPherson Dr Mark Hudson Professor Margaret Bassendine	Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England	2011
Professor Stuart McPherson Dr Mark Hudson Professor Margaret Bassendine	Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England	2011
Dr Mark Hudson	Acute liver failure: Current european perspective	2010
Dr Imran Patanwala Dr Mark Hudson	Hepatology training in the United Kingdom - results of a national trainees' survey	2010
Dr Imran Patanwala Dr Mark Hudson	How confident are UK gastroenterology trainees in managing liver conditions?	2010
Dr Mark Hudson Professor Stuart McPherson Professor Alastair Burt Professor Margaret Bassendine	Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus	2010
Dr Mark Hudson Professor Stuart McPherson Professor Alastair Burt Professor Margaret Bassendine	Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus	2010
Dr Joseph Gray Dr Dipanker Chattopadhyay Dr Gary Beale Dr Gillian Patman Dr Luca Miele et al.	A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease	2009
Dr Ahmad Al-Rifai Dr Martin Prince Emerita Professor Julia Newton Dr Mark Hudson	Fatigue in PSC Patients With and Without Inflammatory Bowel Disease	2009
Dr Stuart Kendrick Dr Mark Hudson Dr Stephen Stewart	White Cell Count and Platelet Count Associate with Histological Alcoholic Hepatitis in Jaundiced Harmful Drinkers	2009
Dr Gary Beale Dr Dipanker Chattopadhyay Dr Joseph Gray Dr Stephen Stewart Dr Mark Hudson et al.	AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease	2008
Dr Helen Marshall Dr Helen Robertson Professor Alastair Burt Professor David Jones Emeritus Professor John Kirby et al.	Biliary epithelial to mesenchymal transition contributes to portal tract fibrogenesis in primary sclerosing cholangitis	2008
Emeritus Professor John Kirby Dr Helen Robertson Dr Helen Marshall Dr Karolina Rygiel Dr Mark Hudson et al.	Epithelial to mesenchymal transition in primary sclerosing cholangitis	2008
Emeritus Professor John Kirby Dr Helen Robertson Helen Marshall Dr Karolina Rygiel Dr Mark Hudson et al.	Epithelial to mesenchymal transition in primary sclerosing cholangitis	2008
Dr Martin Prince Professor Margaret Bassendine Dr Mark Hudson Emeritus Professor Oliver James Professor David Jones et al.	A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis	2007
Leo Smith Bryon Jaques Dr Kaushik Agarwal Dr Mark Hudson David Talbot et al.	Do laparoscopy and intraoperative ultrasound have a role in the assessment of patients with end-stage liver disease and hepatocellular carcinoma for liver transplantation?	2007
Dr Mark Hudson Professor Simon Thomas	Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds	2007
Dr Mark Hudson Professor Simon Thomas	Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds	2007
Dr Mark Hudson	Minimally-elevated liver function tests: Are we seeing or doing enough?	2007
Dr Mark Hudson Professor Derek Manas	Non-transplant surgery for dominant stricture in primary sclerosing cholangitis: Revisited	2007
Emerita Professor Julia Newton Dr Mark Hudson Jessie Pairman Professor David Jones	Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis	2007
Professor Alastair Burt Dr Mark Hudson Professor Margaret Bassendine	The effect of calcineurin inhibitor usage on hepatic fibrosis progression in HCV-positive liver transplant recipients: A two-centre study.	2007
Dr Mark Hudson	An alcoholic patient who continues to drink: endoscopic treatment is preferred	2006
Professor Neil Rajan Dr Andrew Carmichael Dr Michael Bramble Dr Mark Hudson	Cutaneous xanthomatosis: a novel presentation of hypercholesterolaemia in primary sclerosing cholangitis	2006
Dr Kaushik Agarwal Professor Derek Manas Dr Mark Hudson	How good are we at minimising cardiovascular risk following orthotopic liver transplant?	2006
Dr Kaushik Agarwal Professor Derek Manas Dr Mark Hudson	MELD, MELD-s and donor graft quality do not predict patient or graft survival post liver transplant.	2006
Dr Mark Hudson Joanne Newton Dr Martin Prince Professor David Jones	An evidence-based model for the targeting of varices screening in PBC	2005
Professor Jeremy Parr Dr Mark Hudson	Audit of acute variceal bleeding in a tertiary referral centre	2005
Dr Fraser Charlton Dr Mark Hudson Dr Clifford Lawrence	Cutaneous calcification following liver transplantation	2005
Dr Mark Hudson Dr Christopher Snowden Dr Ahmed Chishti Professor Derek Manas Dr Kaushik Agarwal et al.	Liver transplantation in acute liver failure: Intracranial pressure monitoring optimizes patient selection and outcome	2005
Richard Charnley Mark Griffin Nick Hayes Dr Mark Hudson Dr Kenneth Matthewson et al.	One year prospective audit of ERCP across one hospital trust	2005
Dr Mark Hudson	Post orthoptic liver transplant complications in primary sclerosing cholangitis	2005
Dr Mark Hudson Professor Simon Thomas	[abstract] Inappropriate delay in acetylycysteine administration in patients with paracetamol overdose who subsequently develop severe liver dusfunction	2004
Dr Mark Hudson Professor Simon Thomas	Frequency of serious hepatic dysfunction when paracetamol concentrations are below current United Kingdom nomogram treatment lines	2004
Dr Mark Hudson	UK legislation on analgesic packs: before and after study of long term effect on poisonings	2004
Dr Martin Prince Emeritus Professor Oliver James Professor Chris Day Dr Mark Hudson Professor David Jones et al.	Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience	2003
Dr Martin Prince Dr Mark Hudson Professor Chris Day Emeritus Professor Oliver James Professor David Jones et al.	Pain as a complication of use of opiate antagonists for symptom control in cholestasis	2003
Dr Martin Prince Dr Peter Donaldson Dr Mark Hudson	Survival in patients with primary sclerosing cholangitis (PSC). A comparitive study of available prognostic indices	2003
Professor David Jones Dr Martin Prince Dr Mark Hudson	The Mayo prognostic score fails to predict increased mortality associated with portal hypertension in primary biliary cirrhosis (PBC)	2003
Emeritus Professor John Kirby Michael Bone Dr Helen Robertson Dr Mark Hudson Professor David Jones et al.	The number of intraepithelial T cells decreases from ascending colon to rectum [1]	2003
Dr Mark Hudson Dr Katherine Orr	A mass in the liver	2002
Dr Martin Prince Dr Mark Hudson	Alcoholic hepatitis with ascites may mimic advanced ovarian malignancy	2002
Dr Martin Prince Dr Mark Hudson	Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages	2002
Dr Kaushik Agarwal Professor David Jones Professor Alastair Burt Dr Mark Hudson Emeritus Professor Oliver James et al.	Metastatic breast carcinoma presenting as acute liver failure and portal hypertension	2002
Alison Sutherland-Craggs Dr John Mansfield Dr Mark Hudson Professor Ann Daly Emeritus Professor Roger Francis et al.	Osteoporosis in Crohn's disease is not determined by NOD2 genotype [abstract]	2002
Dr Martin Prince Emeritus Professor Oliver James Professor Chris Day Dr Mark Hudson Professor David Jones et al.	Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience	2002
Dr Mark Hudson Michael Thick Sheridan Pollard Dr Aiste McCormick	Tacrolimus versus microemulsified cyclosporine in liver transplantation - The TMC randomised trial. Final results at one year	2002
Professor David Jones Dr Martin Prince Dr Mark Hudson	The impact of portal hypertension in primary biliary cirrhosis (PBC)	2002
Professor David Jones Dr Martin Prince Dr Mark Hudson	The mayo prognostic score fails to predict increased mortality associated with portal hypertension in primary biliary cirrhosis	2002
Professor David Jones Dr Martin Prince Dr Mark Hudson	The prevalence of portal hypertension (PHT) in primary biliary cirrhosis (PBC) [abstract]	2002
Dr Ann Curtis Dr Mark Welfare Dr Mark Hudson Dr Peter Donaldson Dr John Mansfield et al.	Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and crohn disease in multiple populations from northeast England	2001
Professor Chris Day Julian Leathart Professor Ann Daly Dr Mark Hudson	Association of a 5'-flanking region polymorphism in the interleukin-4 gene with Crohn’s disease in a British population.	2001
Professor Chris Day Julian Leathart Professor Ann Daly Dr Mark Hudson	Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population	2001
Dr Stephen Stewart Dr Mark Hudson David Talbot Professor Derek Manas Professor Chris Day et al.	Mycophenolate mofetil monotherapy in liver transplantation	2001
Dr Kaushik Agarwal Professor Ann Daly Julian Leathart Dr Mark Hudson Professor Chris Day et al.	Polymorphisms of immunoregulatory genes: A step towards individually tailored immunosuppression?	2001
Dr Alison Sutherland Professor Chris Day Dr Mark Welfare Professor Ann Daly Dr John Mansfield et al.	Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease	2001
Vicki Strugala Paul Hainsworth Dr Mark Bennett Dr Mark Hudson Professor Jeffrey Pearson et al.	Thickness and continuity of the human colonic mucus layer is decreased in active UC but remains normal in quiescent UC	2001
Dr Kaushik Agarwal Dr John Rose Dr Mark Hudson Professor David Jones	TIPSS in PBC: Lessons regarding the role played by variceal bleeding in disease prognosis	2001
Professor John Magee Dr Mark Hudson Professor Derek Manas Professor Kate Gould Dr Katherine Orr et al.	Tuberculosis transmitted through transplantation	2001
Dr Nicholas Thompson Dr Christopher Record Dr Mark Hudson	Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment?	2000
Professor Kofi Oppong Dr Mark Hudson Dr Christopher Record	Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial	2000
Dr Martin Prince Professor Simon Thomas Emeritus Professor Oliver James Dr Mark Hudson	Reduction in incidence of severe paracetamol poisoning	2000
Dr Martin Prince Professor Simon Thomas Emeritus Professor Oliver James Dr Mark Hudson	Restrictions in availability of paracetamol (PAR) have been associated with a reduction in the incidence of PAR induced liver failure	2000
Michael Bone Emeritus Professor John Kirby Dr Helen Robertson Professor Alastair Burt Dr Mark Hudson et al.	Ulcerative colitis: An investigation of the potential role played by a B-E(7) +VE T-cells	2000
Dr Kaushik Agarwal Professor David Jones Professor Ann Daly Professor Margaret Bassendine Dr Mark Hudson et al.	CTLA-4 gene polymorphism and susceptibility to inflammatory bowel disease (IBD)	1999
Professor David Jones Emeritus Professor Oliver James Professor Alastair Burt Dr Mark Hudson	Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis	1999
Dr Sarah Jowett Dr John Tapson Dr Mark Hudson Neill Thompson	Gastric wall haematoma as a complication of percutaneous endoscopic gastrostomy insertion	1999
Dr Nicholas Thompson Dr Richard Lendrum Dr Mark Hudson Paul Hainsworth Emeritus Professor Roger Francis et al.	Osteoporosis in Crohn's disease: A systematic study of patients in the north east of England	1999
Dr John Rose Emeritus Professor Oliver James Dr Mark Hudson	Portal hypertension secondary to arterioportal fistulae: two unusual cases	1999
Dr Kaushik Agarwal Professor Derek Manas Dr Mark Hudson	Terbinafine and fulminant hepatic failure	1999
Professor Helen Reeves Professor Derek Manas Professor Margaret Bassendine Dr Mark Hudson Emeritus Professor Oliver James et al.	Intravenous bisphosphonate pre liver transplant prevents osteoporotic vertebral collapse	1996